DR PEPPER SEVEN UP COMPANIES INC /DE/
10-Q, 1995-11-13
BEVERAGES
Previous: WINDSOR PARK PROPERTIES 6, 10QSB, 1995-11-13
Next: IEA INCOME FUND IX L P, 10-Q, 1995-11-13



<PAGE>

                               UNITED STATES
                    SECURITIES AND EXCHANGE COMMISSION
                          WASHINGTON, D.C.  20549

                          _______________________

                                 FORM 10-Q
(MARK ONE)
    [X]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
         EXCHANGE ACT OF 1934

             FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 1995

                                    OR

    [ ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
         EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD _________________   TO   _________________

COMMISSION FILE NUMBER:  1-10064


                          _______________________



                    DR PEPPER/SEVEN-UP COMPANIES, INC.
          (Exact Name of Registrant as specified in its charter)


                DELAWARE                              75-2233365
      (State  or other jurisdiction of            (I.R.S. Employer
      incorporation or organization)             Identification No.)


         8144 WALNUT HILL LANE
             DALLAS, TEXAS                          75231-4372
(Address of principal executive offices)            (Zip Code)


                              (214) 360-7000
           (Registrant's telephone number, including area code)

Indicate  by  check mark whether the Registrant (1) has filed  all  reports
required to be filed by Section 13 or 15(d) of the Securities Exchange  Act
of 1934 during the preceding 12 months (or for such shorter period that the
Registrant was required to file such reports), and (2) has been subject  to
such filing requirements for the past 90 days.     [X] Yes    [ ] No

The  number  of  shares  of  each class of the  Registrant's  common  stock
outstanding as of September 30, 1995 was as follows:  61,810,703 shares  of
Common Stock.



                                     1

<PAGE>

                    DR PEPPER/SEVEN-UP COMPAN IES,  INC.
                                   INDEX




                       PART I-FINANCIAL INFORMATION

<TABLE>
<CAPTION>
                                                                           PAGE
                                                                           ----
<S>                                                                         <C>
Item 1.  Financial Statements


           Consolidated  Condensed Balance Sheets

                 September 30, 1995 and December 31, 1994                    3


           Consolidated Condensed Statements of Operations

                 Three and nine months ended September 30, 1995 and 1994     4


           Consolidated Condensed Statement of Stockholders' Deficit


                 Nine months ended September 30, 1995                        5


           Consolidated Condensed Statements of Cash Flows

                 Nine months ended September 30, 1995 and 1994               6

           Notes to Consolidated Condensed Financial Statements              7



Item 2.  Management's Discussion and Analysis of Financial Condition
          and Results of Operations                                         14



                          PART II-OTHER INFORMATION


Item 1.  Legal Proceedings                                                  16
Item 6.  Exhibits and Reports on Form 8-K                                   16

</TABLE>




                                     2


<PAGE>

            DR PEPPER/SEVEN-UP COMPANIES, INC. AND SUBSIDIARIES
                  CONSOLIDATED CONDENSED BALANCE SHEETS
                    (IN THOUSANDS, EXCEPT SHARE DATA)

<TABLE>
<CAPTION>
                                                    SEPTEMBER 30,    DECEMBER 31,
                                                         1995            1994
                                                    -------------    ------------
                                                     (UNAUDITED)
                    ASSETS
- ---------------------------------------------------
<S>                                                   <C>                  <C>
Current assets:
   Accounts receivable, less allowance for
    doubtful accounts of $1,956 in 1995 and
    $1,668 in 1994                                    $  90,735           80,995
   Inventories                                           16,960           16,648
   Prepaid advertising and other current assets           4,689           22,892
   Deferred income taxes                                  8,198           23,532
                                                      ---------         --------
     Total current assets                               120,582          144,067
                                                      ---------         --------
Property, plant and equipment, net                       18,244           18,607

Intangible assets                                       538,317          538,317
Less accumulated amortization                           134,365          124,538
                                                      ---------         --------
     Total intangible assets, net                       403,952          413,779
                                                      ---------         --------
Other assets, net                                        13,843           32,265
                                                      ---------         --------
     Total assets                                    $  556,621          608,718
                                                     ==========         ========

LIABILITIES AND STOCKHOLDERS' DEFICIT
- -----------------------------------------------------
Current liabilities:
   Accounts payable                                  $   30,398           19,999
   Accrued expenses                                     102,948           81,454
   Current portion of long-term debt                         67          100,067
   Due to Cadbury                                        36,663                -
                                                      ---------         --------
      Total current liabilities                         170,076          201,520
                                                      ---------         --------
Long-term debt, less current portion                    273,422          693,159
Due to Cadbury                                          400,000                -
Deferred credits and other                                9,720           15,178
Deferred income taxes                                    26,433           42,971
Stockholders' deficit:
   Common Stock, $.01 par value,  61,810,703 shares
      in 1995 and 61,771,287 shares in 1994 issued          617              617
   Additional paid-in capital                           606,033          416,203
   Accumulated deficit                                 (929,858)        (761,153)
   Foreign currency translation adjustment                  178              223
                                                      ---------         --------
     Total stockholders' deficit                       (323,030)        (344,110)
                                                      ---------         --------
     Total liabilities and stockholders' deficit     $  556,621          608,718
                                                     ==========         ========
</TABLE>

See accompanying notes to consolidated condensed financial statements.


                                     3
<PAGE>

        DR PEPPER/SEVEN-UP COMPANIES, INC. AND SUBSIDIARIES
         CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS
 FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 1995 AND 1994
                           UNAUDITED
           (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)

<TABLE>
<CAPTION>
                                       THREE MONTHS           NINE MONTHS
                                    -------------------   --------------------
                                      1995       1994        1995       1994
                                    --------   --------   ---------   --------
<S>                                 <C>        <C>        <C>         <C>
Net sales                           $208,678   $201,928   $ 611,736   $585,058
Cost of sales                         34,838     34,122     104,316     98,755
                                    --------   --------   ---------   --------
          Gross profit               173,840    167,806     507,420    486,303
                                    --------   --------   ---------   --------

Operating expenses:
  Marketing                          104,743    103,819     444,040    296,489
  General and administrative           9,407      7,871     144,154     24,187
  Amortization of intangible assets    3,276      3,277       9,828      9,828
                                    --------   --------   ---------   --------
    Total operating expenses         117,426    114,967     598,022    330,504
                                    --------   --------   ---------   --------

    Operating profit (loss)           56,414     52,839     (90,602)   155,799

Other income (expense):
  Interest expense                   (18,431)   (18,550)    (53,074)   (55,160)
  Other, net                            (116)      (273)    (10,165)    (1,080)
                                    --------   --------   ---------   --------

    Income (loss) before income
      taxes and extraordinary item    37,867     34,016    (153,841)    99,559

Income tax expense (benefit)           2,737     12,040        (601)    36,073
                                    --------   --------   ---------   --------

    Income (loss) before
      extraordinary item              35,130     21,976    (153,240)    63,486

Extraordinary item - extinguishments
  of debt less applicable income
  taxes of $0 and $5,030,
  respectively                           -        1,229      15,465      9,341
                                    --------   --------   ---------   --------
    Net income (loss)               $ 35,130   $ 20,747   $(168,705)  $ 54,145
                                    ========   ========   =========   ========

Income (loss) per common share
  and share equivalents:
      Income (loss) before
        extraordinary item          $   0.51   $   0.30   $   (2.22)  $   0.92
      Extraordinary item                -         (0.02)       (.23)     (0.14)
                                    --------   --------   ---------   --------
      Net income (loss)             $   0.51   $   0.28   $   (2.45)  $   0.78
                                    ========   ========   =========   ========

Weighted average shares and
  share equivalents outstanding       68,924     66,913      68,924     66,949
                                    ========   ========   =========   ========
</TABLE>

See accompanying notes to consolidated condensed financial statements.

                                4

<PAGE>

         DR PEPPER/SEVEN-UP COMPANIES, INC. AND SUBSIDIARIES
      CONSOLIDATED CONDENSED STATEMENT OF STOCKHOLDERS' DEFICIT
           FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1995
                            UNAUDITED
                          (IN THOUSANDS)

<TABLE>
<CAPTION>
                                                                                  FOREIGN      TOTAL
                                   NUMBER            ADDITIONAL                  CURRENCY      STOCK-
                                     OF      COMMON    PAID-IN    ACCUMULATED   TRANSLATION    HOLDERS'
                                   SHARES    STOCK     CAPITAL      DEFICIT      ADJUSTMENT    DEFICIT
                                   ------    ------  ----------   -----------   -----------   ---------
<S>                                <C>       <C>     <C>          <C>           <C>
Balance at December 31, 1994       61,765     $617     $416,203     $(761,153)       $223     $(344,110)

Capital Contribution from Cadbury       -        -      190,526             -           -       190,526

Exercise of employee stock
  options, including tax benefits      39        -          567             -           -           567

Net loss                                -        -            -      (168,705)          -      (168,705)

Other                                   -        -       (1,263)            -         (45)       (1,308)
                                   ------     ----     --------     ---------        ----     ---------
Balance at September 30, 1995      61,804     $617     $606,033     $(929,858)       $178     $(323,030)
                                   ======     ====     ========     =========        ====     =========
</TABLE>

See accompanying notes to consolidated condensed financial statements.

                                  5


<PAGE>

         DR PEPPER/SEVEN-UP COMPANIES, INC. AND SUBSIDIARIES
           CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS
        FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1995 AND 1994
                               UNAUDITED
                             (IN THOUSANDS)

<TABLE>
<CAPTION>
                                                     1995         1994
                                                  ---------    ---------
<S>                                               <C>          <C>
Cash flows from operating activities:
   Net income (loss)                              $(168,705)      54,145
   Adjustments to reconcile net income (loss)
     to net cash provided by operating
     activities:
      Depreciation and amortization of
        intangibles, debt discounts and
        deferred debt issuance costs                 34,858       40,820
      Deferred income taxes                          (1,204)      17,416
      Debt restructuring charge                      15,465        1,603
      Changes in assets and liabilities:
        Accounts receivable                          (9,740)     (13,156)
        Inventories                                    (312)      (2,469)
        Prepaid advertising and other assets         20,013       (5,100)
        Accounts payable and accrued expenses        26,772      (17,868)
        Other                                        (6,117)       7,750
                                                  ---------    ---------
           Net cash provided by (used in)
             operating activities                   (88,970)      83,141
                                                  ---------    ---------
Cash flows from investing activities:
     Capital expenditures                            (2,098)      (1,591)
     Other                                             (400)        (697)
                                                  ---------    ---------
           Net cash used in investing activities     (2,498)      (2,288)
                                                  ---------    ---------
Cash flows from financing activities:
     Capital Contribution from Cadbury for
       stock option payout                          190,526         -
     Proceeds of borrowings from Cadbury            560,500         -
     Payments on borrowings from Cadbury           (123,837)        -
     Proceeds from long-term debt                    75,845      207,000
     Payments on long-term debt                    (616,889)    (276,335)
     Retirement of subordinated debt                    -        (13,902)
     Increase  in cash overdraft                      5,121          139
     Other                                              202        2,245
                                                  ---------    ---------
           Net cash provided by (used in)
             financing activities                    91,468      (80,853)
                                                  ---------    ---------
Net increase in cash and cash equivalents               -           -
Cash and cash equivalents at beginning of
  period                                                -           -
                                                  ---------    ---------
Cash and cash equivalents at end of period        $     -           -
                                                  =========    =========
</TABLE>

See accompanying notes to consolidated condensed financial statements.

                                    6

<PAGE>

     DR PEPPER/SEVEN-UP COMPANIES, INC. AND SUBSIDIARIES
    NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
                          UNAUDITED
                     SEPTEMBER 30, 1995


1.  GENERAL

    The  accompanying consolidated condensed  balance  sheet
    as  of  September  30, 1995, the consolidated  condensed
    statements  of operations for the three and nine  months
    ended  September  30,  1995 and 1994,  the  consolidated
    condensed  statement of stockholders'  deficit  for  the
    nine   months   ended  September  30,   1995   and   the
    consolidated condensed statements of cash flows for  the
    nine  months  ended  September 30,  1995  and  1994  are
    unaudited  but  include, in the opinion  of  management,
    all  adjustments  (consisting only of  normal  recurring
    accruals)  necessary  for  a fair  presentation.   These
    financial statements are for interim periods and do  not
    include  all   detail   normally  provided   in   annual
    financial   statements.   They   should   be   read   in
    conjunction    with     the    consolidated    financial
    statements  of  Dr Pepper/Seven-Up Companies,  Inc.  and
    subsidiaries  for  the  year  ended  December  31,  1994
    included in the Company's Annual Report on Form 10-K.

    As  a  consequence of the acquisition of the Company  by
    Cadbury  (see  Note 2 below), the results of  operations
    for  the  nine months ended September 30, 1995  are  not
    necessarily  indicative  of the operating  results  that
    may  be expected for the full fiscal year.  Included  in
    expenses  are certain non-recurring items consequent  to
    the acquisition.

    As   hereinafter  used,  unless  the  context   requires
    otherwise,   the   "Company"  means  Dr  Pepper/Seven-Up
    Companies,  Inc. together with its direct  and  indirect
    subsidiaries,   and   the   "Holding   Company"    means
    Dr  Pepper/Seven-Up Companies, Inc.  Dr  Pepper/Seven-Up
    Corporation ("DP/7UP") is a direct operating  subsidiary
    of the Holding Company.

    Income (loss) per common share and share equivalents  is
    based  on  the  income (loss) applicable  to  the  fully
    diluted  weighted  average  number  of  shares  of   the
    Company's  common  stock,  par  value  $.01  per   share
    ("Common    Stock"),   outstanding   of    approximately
    68,924,000  and 66,913,000 shares for the  three  months
    ended  September  30, 1995 and 1994,  respectively,  and
    68,924,000  and  66,949,000 shares for the  nine  months
    ended   September  30,  1995  and  1994,   respectively.
    Shares  issuable  upon  exercise of  stock  options  and
    warrants are excluded from the 1995 calculation  because
    they  are antidilutive.  For 1994, the weighted  average
    number  of  shares  of Common Stock outstanding  assumes
    the  exercise of dilutive stock options.  Income  (loss)
    per  common share and share equivalents is the same  for
    primary and fully diluted per share amounts.

2.    ACQUISITION   OF   THE   COMPANY   BY   CADBURY   (THE
     "ACQUISITION")

    On  January  25,  1995,  the  Holding  Company,  Cadbury
    Schweppes  plc, a company organized under  the  laws  of
    England  ("Cadbury"),  and  DP/SU  Acquisition  Inc.,  a
    Delaware  corporation  and  an  indirect  wholly   owned
    subsidiary  of  Cadbury ("Purchaser"), entered  into  an
    Agreement  and Plan of Merger (the "Merger  Agreement").
    Pursuant  to the Merger Agreement, on February 1,  1995,
    Purchaser  commenced  a tender offer  (the  "Offer")  to
    acquire  all  issued and outstanding  shares  of  common
    stock  of  the  Holding  Company  ("Common  Stock")  not
    already  owned  by  Cadbury at a  price  of  $33.00  per
    share.  The Offer expired, as scheduled, at midnight  on
    Wednesday, March 1, 1995.  A total of 45,387,180  shares
    of   Common   Stock


                                 7



<PAGE>

    were tendered and  purchased by  Purchaser  pursuant  to
    the Offer.  As a result  of  such    purchase  and   the
    prior  acquisition of shares of  Common Stock, Purchaser
    and other wholly owned  subsidiaries  of  Cadbury  owned
    approximately 98.7% of the issued and outstanding shares
    of  Common Stock.  Upon the  approval   and  adoption of
    the Merger Agreement  by  the  affirmative   vote of the
    stockholders  of  the  Company  at  a   meeting  of  the
    stockholders  of  the  Holding  Company held on June  5,
    1995,  a wholly owned subsidiary of Purchaser was merged
    (the  "Merger") with and into the Company.  As a  result
    of  the  Merger, each share of Common Stock (other  than
    shares held in the treasury of the Company, or owned  by
    Cadbury   or  any  of  its  subsidiaries  or   held   by
    stockholders  who  filed  with  the  Company  a  written
    objection  to the Merger and had not voted in  favor  of
    the  Merger  and who have properly demanded  in  writing
    and  perfected  appraisal for such shares in  accordance
    with   the   laws   of  the  State  of  Delaware),   was
    automatically  converted  into  the  right  to   receive
    $33.00   in   cash,   without  interest.    Accordingly,
    Purchaser   and  other  wholly  owned  subsidiaries   of
    Cadbury  now  own  100%  of the issued  and  outstanding
    shares of Common Stock.

    Pursuant  to  the  terms of the Merger  Agreement,  each
    outstanding  option to purchase shares  of  the  Holding
    Company's  Common  Stock  granted  under  the  Company's
    various  stock option plans, whether or not exercisable,
    was  canceled.  Each holder of canceled options received
    an  amount  in  cash  equal to the product  of  (1)  the
    number  of shares previously subject to such option  and
    (2)  the  excess  of $33 per share over  the  applicable
    exercise  price.  In connection therewith, Cadbury  made
    a   capital  contribution  of  $190.5  million  to   the
    Company, representing the total cash payments   made  to
    all option holders.

    The  foregoing description of the Merger Agreement is  a
    summary  only  and  is  qualified  in  its  entirety  by
    reference to the copy of the Merger Agreement  filed  as
    Exhibit  2.1 to the Company's 1994 Form 10-K,  which  is
    incorporated herein by reference in its entirety.

3.  LONG-TERM DEBT/RELATED PARTY TRANSACTIONS

    In   connection  with  the  Acquisition,   the   Company
    borrowed $500.0 million from Cadbury (reduced to  $400.0
    million on May 19, 1995) which has been classified as  a
    long-term   payable  in  the  accompanying  consolidated
    balance sheet.  These borrowings bear interest at  9.5%.
    The  Company also received a working capital  loan  from
    Cadbury.  The balance of that loan was $36.7 million  at
    September   30,   1995  and  is  included   in   current
    liabilities  in  the  accompanying consolidated  balance
    sheet.

    The  Company used the proceeds from Cadbury to repay its
    outstanding  borrowings under the Credit Agreement.   In
    connection  therewith,  the  Company  recorded  a  $15.5
    million  extraordinary  charge reflecting  write-off  of
    the  unamortized balance of deferred debt issuance costs
    related to the Credit Agreement.

4.  INVENTORIES

    Inventories consisted of the following at September  30,
    1995 and December 31, 1994 (in thousands):

<TABLE>
<CAPTION>
                                       1995        1994
                                    ---------    -------
        <S>                            <C>        <C>
        Finished products           $   6,121      6,449
        Raw materials and supplies     10,839     10,199
                                    ---------    -------
             Total inventories      $  16,960     16,648
                                    =========    =======
</TABLE>



                              8


<PAGE>


5.  CONTINGENCIES

    (a)  THE COCA-COLA COMPANY ("COKE") LITIGATION

          On  February 26, 1992, Seven-Up filed a lawsuit in
          the  116th  Judicial Court, Dallas  County,  Texas
          (the  "State  Court Suit") against Coke  alleging,
          among  other  things, tortious  interference  with
          Seven-Up's existing contractual relationships with
          those  licensed bottlers who also bottle  products
          of  Coke,  and unfair competition.   On  July  22,
          1992,  Seven-Up also filed a lawsuit against  Coke
          in  the  United  States  District  Court  for  the
          Northern  District  of Texas (the  "Federal  Court
          Suit") alleging false advertising under Section 43
          of  the  Lanham  Act.  On October 3,  1994,  trial
          before a jury commenced in the Federal Court Suit.
          The  jury  found  for Seven-Up, awarding  it  $2.5
          million  damages.  However, the federal magistrate
          overturned   the  jury's  verdict,  finding   that
          although  Coke  had engaged in false  advertising,
          Seven-Up had suffered no damages thereby.   Seven-
          Up  has  appealed the magistrate's ruling  to  the
          Fifth Circuit Court of Appeals, and Coke has filed
          a   cross-appeal.    These  appeals   are   in   a
          preliminary briefing phase at this time.

          Following the magistrate's rulings in the  Federal
          Court Suit, Coke moved for summary judgment in the
          State Court Suit on procedural grounds.  The state
          court  judge  granted Coke's  motion  for  summary
          judgment  on  Seven-Up's claims.   Coke  had  also
          filed  counterclaims  in  the  State  Court   Suit
          alleging  that Seven-Up had tortiously  interfered
          with  Coke's  existing  contractual  relationships
          with  those licensed bottlers of Coke who are also
          licensed   to   bottle  Sprite   products.    That
          counterclaim is still pending in the state  court.
          The court has severed the counterclaim from Seven-
          Up's claims and abated it, which has enabled Seven-
          Up  to  appeal the state court's ruling on  Coke's
          motion for summary judgment.

          The  Company  intends  to  vigorously  pursue  its
          claims  on  appeal,  but is  presently  unable  to
          predict  the  outcome  of  these  lawsuits.    The
          Company  does  not expect that the  resolution  of
          these  matters will have a material adverse effect
          on  the  Company's operating results or  financial
          condition.

    (b)  INTERNAL REVENUE SERVICE MATTER

         The  Internal  Revenue Service  has  completed  its
         examination  of  Federal  income  tax  returns   of
         Dr  Pepper  Company ("Dr Pepper") and The  Seven-Up
         Company  ("Seven-Up"),  predecessors   in  interest
         to  DP/7UP,  for  the  periods ended  December  31,
         1986,   December 31, 1987  and  May 19,  1988,  and
         of  the  Company for the period ended December  31,
         1988.   The  Company was notified of  proposed  IRS
         adjustments    disallowing   certain    deductions,
         including   substantially   all   amortization   of
         intangible  assets related to the 1986 acquisitions
         of  Dr  Pepper  and  Seven-Up.  During  the  second
         quarter of 1994, the Company accepted a global  tax
         settlement  from the  IRS with respect  to  certain
         proposed  adjustments relating to the deductibility
         of  a portion of intangible assets. As a result  of
         the  settlement, the Company reduced  its  recorded
         deferred  tax  liabilities by  approximately  $65.0
         million.    The   corresponding  effect   of   this
         adjustment to deferred tax liabilities was  applied
         as  a  reduction of intangible assets for financial
         reporting purposes.  If the remaining proposed  IRS
         adjustments are sustained, in whole  or  in   part,
         the  Company's net operating loss carryforwards for
         Federal  income tax purposes would be significantly
         reduced.  The Company is vigorously contesting  the
         remaining proposed adjustments.  Management of  the
         Company  believes  the ultimate resolution  of  the
         remaining  proposed adjustments  will  not  have  a
         material  adverse effect on the Company's operating
         results or financial condition.


                                9

<PAGE>

         (c) SHAREHOLDER LITIGATION

         On  October 26, 1994, a complaint styled KING V. DR
         PEPPER/SEVEN-UP  COMPANIES, ET AL.   ("King"),  was
         filed  in  the U.S. District Court for the Northern
         District  of Texas, Dallas Division, alleging  that
         the  defendants  violated  Section 10(b)  and  Rule
         10b-5  under the Exchange Act  by failing to reveal
         the true status of merger discussions  between  the
         Company  and  Cadbury.  The complaint alleges  that
         the  defendants knowingly or recklessly engaged  in
         a   plan  to  depress  the  market  price  of   the
         Company's  securities by misstating and  concealing
         material information concerning the true status  of
         merger discussions with Cadbury.  In addition,  the
         complaint   alleges  that  John  Albers,   formerly
         President  and  Chief  Executive  Officer  of   the
         Company,  violated Section 20(a)  of  the  Exchange
         Act  by failing to disseminate truthful information
         with  respect  to  the Company's business.   Relief
         requested   includes   unspecified   damages    and
         expenses (including attorneys' fees).  As a  result
         of  defendants'  motion to  dismiss  based  on  the
         plaintiff's   failure   to   plead    fraud    with
         specificity  and  failure  to  state  a  claim  for
         securities  fraud, on January 24, 1995,  the  judge
         in  the  suit  issued  an  Order  to  File  Amended
         Complaint   to  the  plaintiff,  which   gave   the
         plaintiff  20 days in which to amend her  complaint
         to  cure  the  deficiencies  noted  in  the  order.
         Subsequently,  Plaintiff amended the  complaint  to
         cure   the   Court's  concerns.   After  conducting
         discovery on the merits, Plaintiff filed  a  motion
         for  summary  judgment.  Defendants filed  a  cross
         motion  for  summary judgment  and  a  response  to
         Plaintiff's motion.  By order dated June 28,  1995,
         the  Court  ordered  the parties  to  mediation  to
         determine whether the case could be settled.

         At  mediation,  the  parties  reached  a  tentative
         settlement  agreement,  which  is  memorialized  in
         Stipulation  of  Settlement,  dated  September  14,
         1995    (the   "Stipulation").    The   Stipulation
         provides  for  a settlement of the King  litigation
         and  includes the following general terms:  (i) the
         certification  of the King litigation  as  a  class
         action  under  Federal Rule of Civil Procedure  23,
         which  class  will consist of persons who  sold the
         Company's common  stock or  call options to acquire
         the Company's stock (as defined in the Stipulation)
         during  the  period  on and between  September  30,
         1994 and October 25, 1994; (ii) the release of  all
         claims,  rights, causes of action, suits,  matters,
         and  issues, whether known or unknown,  that  could
         have  been  or in the future might be  asserted  in
         the King litigation or any court or proceeding,  by
         any   member  of  the  proposed  settlement   class
         against  Defendants  and their respective  past  or
         present  directors, officers, employees,  partners,
         members,    principals,    agents,    underwriters,
         issuers,   co-insurers,   reinsurers,   controlling
         shareholders,  attorneys,  accountants,   auditors,
         investment     bankers,     advisors,      personal
         representatives,     predecessors,      successors,
         parents,    subsidiaries,    divisions,    assigns,
         spouses,    heirs,    executors,    administrators,
         associates   (as   defined  in   SEC   Rule   12b-2
         promulgated  pursuant  to the  Securities  Exchange
         Act  of 1934), related or affiliated entities,  any
         members  of their immediate families, or any  trust
         of  which any defendant is the settlor or which  is
         for  the  benefit of any defendant and/or member(s)
         of  his family arising out of, relating to,  or  in
         connection   with   (1)  a  potential   transaction
         involving   the  acquisition  of   the  Company  or
         transactions   or  events  arising   out   of   the
         acquisition of the  Company;  (2)  transactions  or
         events described in any of the complaints filed  in
         the  King  litigation;  (3) disclosures  (including
         any  failure  to make disclosures)  relating  to  a
         potential acquisition of the Company or disclosures
         (including   any   failure  to  make   disclosures)
         described  in  any of the complaints filed  in  the
         King  litigation;  or (4) the  sale  of the Company
         common  stock  or call options (as defined  in  the
         Stipulation)  during  the  proposed  class  period;
         (iii) Defendants have denied, and continue to deny,
         that  any  of them have committed or threatened  to
         commit  any violations of law or breaches  of  duty
         to  Plaintiff or any members of the proposed class;
         and   (iv)   Defendants  are  entering   into   the
         Stipulation solely because the proposed  settlement
         would  eliminate the burden and expense of  further
         litigation,  which they believe to be in  the  best
         interest   of   the  Company   and   all   of   its
         stockholders.    In   addition,   Defendants   have
         deposited  $4,200,000   into  an   interest-bearing
         escrow



                                 10

<PAGE>

         account     (the  "Settlement  Fund").   If     the
         settlement   is   approved  by   the   Court,   the
         Settlement  Fund will be used to pay,  among  other
         things,  Plaintiff's  attorneys'  fees  and  claims
         submitted   by   settlement  class  members.    The
         parties   have  requested  that  the  Court   grant
         preliminary  approval  of the  proposed  settlement
         and  set  a  hearing to consider final approval  of
         the settlement.

         In   connection  with  the  Rights  Agreement   (as
         hereinafter  defined) and the announcement  of  the
         Merger  Agreement  (See Note 2),  several  putative
         class  action complaints (the "Shareholders Suits")
         were  filed in the Court of Chancery of  the  State
         of  Delaware and a state court of Texas naming  the
         Company  and  certain directors as  defendants  and
         alleging   that   the  defendants  breached   their
         fiduciary   duties   to   the   Company   and   its
         stockholders.  These suits are described in item  8
         of  the  Solicitation/Recommendation  Statement  on
         schedule  14D-9  filed  by  the  Company  with  the
         Securities  and Exchange Commission on February  1,
         1995,  as  amended (the "14D-9"), which information
         is  incorporated herein by reference to Exhibit  99
         of the Company's 1994 Form 10-K.

         On February 10, 1995, all of the Shareholder Suits,
         except  for  the King case, were consolidated in IN
         RE: DR PEPPER/SEVEN-UP COMPANIES, INC. SHAREHOLDERS
         LITIGATION,    Civil   Action   No.   13109    (the
         "Consolidated  Action"),  in  the Court of Chancery
         of the State of Delaware (the "Delaware Court"). In
         the Consolidated Action,  plaintiffs and defendants
         (through  their  respective counsel),  have entered
         into a Memorandum of Understanding,  dated February
         21,  1995   (the  "Memorandum  of  Understanding"),
         pursuant  to  which the Consolidated Action will be
         settled. Pursuant to the settlement contemplated by
         the Memorandum of Understanding,  the plaintiffs in
         the  suit  styled  SARNOFF  V.  DR  PEPPER/SEVEN-UP
         COMPANIES  ET  AL.  non-suited  the  action pending
         before  the  Texas  Court  and  refiled it with the
         Delaware Court.  By order dated April 29, 1995, the
         refiled  Sarnoff  case  was  consolidated  with and
         became   part  of  the  Consolidated  Action.   The
         proposed  settlement  is  subject  to,  among other
         things, approval of the Delaware Court and is fully
         described in the 14D-9.

         Pursuant   to  the  terms  of  the  Memorandum   of
         Understanding,   the   parties   entered   into   a
         Stipulation  of  Compromise and  Settlement,  which
         was  filed with the Court on August 28, 1995.   The
         Court  has  set a settlement hearing  for  November
         29,   1995,  to  determine  whether,  among   other
         things,  the  terms of the proposed settlement  are
         fair,   reasonable,  adequate,  and  in  the   best
         interests  of  the  proposed  class,  to  determine
         whether   the   consolidated   action   should   be
         certified  as  a  class action,  and  to  hear  and
         determine   any   objections   to   the    proposed
         settlement.    The   Company  believes   that   the
         resolution  of  this litigation  will  not  have  a
         material  adverse  effect on its operating  results
         or financial condition.

    (d)  STEINER LITIGATION

         Sidney   J.   Steiner,  the  landlord   under   the
         Company's   former   lease  covering   its   former
         headquarters  facilities, and  Harbord  Midtown,  a
         Texas  partnership, filed suit against the  Company
         in   the   95th  Judicial  District  Court,  Dallas
         County,  Texas, on May 25, 1988 in connection  with
         the  Company's  move of its corporate headquarters.
         The  landlord has alleged that the Company breached
         an  oral  agreement to lease space in a new  office
         building the landlord planned to construct on  such
         premises.    The   landlord   seeks   to    recover
         $470,000  in  architectural fees  and  other  costs
         claimed  to have been incurred as a result of  such
         agreement and the landlord claims to have  suffered
         $24.0  million in other damages as a result of  the
         Company's   alleged   breach.    Additionally,   on
         October   12,   1989,  the  landlord  amended   its
         complaint  in  this  cause  of  action  to  include
         allegations    that   the   Company    fraudulently
         misrepresented  the existence of  asbestos  in  the
         Company's  former



                                 11


<PAGE>
         headquarters  facilities,  which  were  purchased by
         the landlord and leased back to the Company in 1985.
         The landlord claims  damages  in   excess   of  $4.0
         million  related   to   the  additional allegations.

         The   lawsuit   was  dismissed  without   prejudice
         pursuant  to an Agreed Order Granting Joint  Motion
         for  Non-Suit  on  May  18,  1992.   Subsequent  to
         filing  the lawsuit, Steiner sold the property  and
         the  claim in litigation to a third party,  who  in
         turn  later  sold  the property and  the  claim  to
         another  party, who became a debtor in a bankruptcy
         proceeding.   The  trustee in bankruptcy  sold  the
         claim   in   the   lawsuit  to   Canco   Properties
         ("Canco"),   San Antonio, Texas, who  refiled   the
         lawsuit  on  January  29, 1993.   By  letter  dated
         September   21, 1993, Canco claimed that additional
         discovery   and   investigation  resulted   in   an
         increase  in  estimated damages, and now  estimates
         their  damages  to  be  over  $31.5  million,  with
         punitive damages in excess of $50.0 million in  the
         aggregate.  On  May  4,  1994,  Canco  amended  its
         petition    to    add    claims    for    negligent
         misrepresentation   and  fraud   based   upon   the
         Company's   alleged   failure   to   disclose   the
         existence  of  water leaks in the building  at  the
         time  the  building was sold to Steiner  in  August
         1985.   On  February 17, 1995, Canco again  amended
         its   petition,  dismissing  its  claims  that  the
         Company  breached  an  alleged  oral  agreement  to
         become   a   tenant  in  a  new  building   to   be
         constructed  by Canco, but adding claims  that  the
         Company  breached the original 1985 sale  agreement
         by  failing to disclose the presence of asbestos on
         the   property.   Canco's  amended  petition  seeks
         unspecified monetary damages and rescission of  the
         original  transaction.  By letter  dated  March  6,
         1995,  Canco now claims their monetary  damages  to
         be    approximately   $35.0   million    (excluding
         interest).  The court granted the Company's  motion
         for  summary  judgment on August 23, 1995.   It  is
         unclear  at  this time whether Canco  will  appeal.
         The  Company believes that this lawsuit is  without
         merit  and is vigorously contesting the same.   The
         Company  further  believes that the  resolution  of
         this  litigation  will not have a material  adverse
         effect   on  its  operating  results  or  financial
         condition.

         On  December  4, 1990, Steiner filed a  claim  with
         the   American   Arbitration  Association   seeking
         compensation  for damage allegedly  caused  by  the
         Company   to   its  former  corporate  headquarters
         building  during  the Company's occupancy  of  such
         building  as  tenant under a lease  agreement  with
         Steiner.  This claim was subsequently sold  in  the
         same   manner   as  described  in  the  immediately
         preceding  paragraph with respect to the litigation
         and  is now owned by Canco.  Canco presently  seeks
         damages  in  connection  with  this  claim  in  the
         amount  of approximately $11.5 million as  well  as
         an  unspecified  amount  of  punitive  damages  and
         attorneys'  fees.   An  arbitration  hearing   with
         respect to this claim began on November 8, 1993  in
         Dallas,  Texas; however, due to the  death  of  the
         arbitrator,  a  new arbitrator was appointed.   The
         parties  conducted  the  arbitration  hearing  from
         June  28  through  July  7, 1994.   The  arbitrator
         awarded  Canco  $150,000  for  its  claims  in  the
         arbitration;   however,  because   the   arbitrator
         determined  that  the Company  was  the  prevailing
         party  in  the arbitration, the arbitrator  awarded
         the  Company  approximately $139,000 in  attorneys'
         fees.   Therefore, the net amount paid to Canco  by
         the   Company  was  approximately  $11,000.   Canco
         filed  suit  in  the 68th Judicial District  Court,
         Dallas   County,  Texas,  seeking  to  vacate   the
         arbitration   award  on  the   grounds   that   the
         arbitrator  was  not  impartial.   Canco  dismissed
         that suit on June 7, 1995.

         (e) RIGHTS AGREEMENT AMENDMENT

         Immediately  prior to the execution of  the  Merger
         Agreement,   the   Company   amended   the   Rights
         Agreement  dated  September 1,  1993,  between  the
         Company  and  Bank  One, Texas, N.A.  (the  "Rights
         Agreement").    This  amendment  (the  "Amendment")
         provides   that  (A)  none  of  the  execution   or
         delivery   of   the   Merger   Agreement   or   the
         Stockholders Agreement or the making of  the  Offer
         will  cause  (i) the Rights (as defined  under  the
         Rights  Agreement) to become exercisable



                                12


<PAGE>

         under   the   Rights   Agreement,  (ii) Cadbury  or
         Purchaser or any of their affiliates  to be  deemed
         an  Acquiring  Person   (as  defined  in the Rights
         Agreement)  or   (iii)  the  Stock Acquisition Date
         (as  defined in  the  Rights  Agreement)  to  occur
         upon  any  such event,  (B)  none of the acceptance
         for payment  or   payment  for  Shares by Purchaser
         pursuant  to  the    Offer  or the consummation  of
         the Merger will cause   (i)  the  Rights  to become
         exercisable  under  the   Rights  Agreement or (ii)
         Cadbury or  Purchaser  or any  of  their affiliates
         to be deemed an Acquiring    Person  or  (iii)  the
         Stock Acquisition  Date  to   occur  upon  any such
         event, and (C) the Expiration    Date  (as  defined
         in the Rights Agreement)  shall    occur  no  later
         than  immediately prior to the purchase  of  shares
         pursuant to  the  Offer.   The    Expiration   Date
         occurred  on  March   2,   1995, immediately  prior
         to  Purchaser's  purchase   of     shares  pursuant
         to the Offer.   Accordingly,  the   Rights expired.

         The  foregoing  description of the Amendment  is  a
         summary  only and is qualified in its  entirety  by
         reference to the form thereof filed as Exhibit  3.4
         to   the   Company's  1994  Form  10-K,  which   is
         incorporated  herein by reference in its  entirety.
         The  Rights Agreement has been filed as Exhibit 3.3
         to that Form 10-K.

         (f) OTHER LITIGATION

         DP/7UP  is  a  defendant in various other  lawsuits
         arising  out  of  the  ordinary  conduct   of   its
         business.   Management of the Company believes  the
         resolution  of  these  matters  will  not  have   a
         material  adverse effect on the Company's operating
         results or financial condition.







                                  13
<PAGE>

     DR PEPPER/SEVEN-UP COMPANIES, INC. AND SUBSIDIARIES

            MANAGEMENT'S DISCUSSION AND ANALYSIS
      OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                     SEPTEMBER 30, 1995

RESULTS OF OPERATIONS - NINE MONTHS ENDED SEPTEMBER 30, 1995
                         COMPARED TO NINE MONTHS ENDED SEPTEMBER 30,
                         1994 AND THREE MONTHS ENDED SEPTEMBER 30,
                         1995 COMPARED TO THREE MONTHS ENDED
                         SEPTEMBER 30, 1994

     Net  sales for the nine months ended September 30, 1995
increased  5%  to $611.7 million compared to $585.1  million
for the nine months ended September 30, 1994.  Net sales for
the  three months ended September 30, 1995 increased  3%  to
$208.7  million  compared to $201.9  million  in  the  third
quarter  of  1994. The increases were primarily the   result
of   increased  sales volume for DR PEPPER brands  over  the
comparable  periods  in  1994, as  well  as  selected  price
increases.

     Cost  of sales for the nine months ended September  30,
1995  increased  6%  to  $104.3 million  compared  to  $98.8
million in the first nine months of 1994.  Cost of sales for
the  three months ended September 30, 1995 increased  2%  to
$34.8 million compared to $34.1 million in the third quarter
of  1994.  Gross profit as a percentage of net sales for the
nine months ended September 30, 1995 decreased from 83.1% in
1994  to  82.9%  in  1995.   These  relationships  primarily
reflect product mix.

      Total  operating  expenses,  which  include  marketing
expense, general and administrative expense and amortization
of intangible assets, increased 81% to $598.0 million in the
first nine months of 1995 compared to $330.5 million in  the
same  period  of  the  prior  year.   These  increases  were
primarily  due to transactions recorded as a result  of  the
increase  by  Cadbury  of  its  ownership  position  of  the
Company's Common Stock on March 2, 1995 (See Note  2).   The
significantly  higher  expenses  (for  both  marketing   and
general and administrative categories) principally relate to
compensation   expense  pertaining  to  the  redemption   of
employee  stock  options, restricted shares,  and  severance
costs  incurred as a result of the Acquisition.  There  also
was an increased provision of marketing expenses as a result
of  higher sales volume.  Total operating expenses  for  the
three months ended September 30, 1995 increased 2% to $117.4
million  from  $115.0 million in the third  quarter  of  the
prior year.

    As a result of the above factors, operating loss for the
nine  months  ended  September 30, 1995  was  $90.6  million
compared to $155.8 million of operating profit in the  first
nine  months of 1994.  Operating profit for the three months
ended September 30, 1995 of $56.4 million was 7% higher than
the  $52.8  million  operating profit earned  in  the  third
quarter of 1994.

    Interest expense for the nine months ended September 30,
1995 decreased 4% to $53.1 million compared to $55.2 million
in  the  third  quarter of 1994.  Interest expense  for  the
three  months ended September 30, 1995 decreased 1% to $18.4
million  compared to $18.6 million in the third  quarter  of
1994.

     Other  expense  for  the  first  nine  months  of  1995
principally  reflects  investment  banking  and  legal  fees
incurred in connection with the Acquisition.

     The  decrease in income tax expense in the nine  months
and  three  months ending September 30, 1995 as compared  to
the  same  periods in 1994 is due to the impact of the  loss
incurred  in 1995.  Additionally, the Company has not  fully
recognized  its potential tax benefits related to  its  1995
loss  due primarily to uncertainty of the Company's  ability
to realize such benefits as a subsidiary of Cadbury.


                              14


<PAGE>

    In connection with the repayment of the Company's credit
agreement (the "Credit Agreement"), an extraordinary  charge
of  $15.5  million was recorded in the first nine months  of
1995.  The extraordinary charge reflects a write-off of  the
unamortized balance of deferred debt issuance costs  related
to the Credit Agreement. (See Note 3.)

     In  connection with the retirement of a portion of  the
Company's  11  1/2% Senior Subordinated Discount  Notes  due
2002 (the "Discount Notes"), an extraordinary charge of $9.3
million  was recorded in the first nine months of 1994,  net
of  a  $5.0  million  tax effect.  The extraordinary  charge
reflects a write-off of a portion of the unamortized balance
of  deferred debt issuance costs as well as the premium paid
in excess of the accreted value.

     As a result of the above factors,  the Company incurred
$168.7 million of net loss in the first nine months of  1995
compared  to $54.1 million of net income earned in the  same
period  in  1994.  For the three months ended September  30,
1995,  the  Company  earned  $35.1  million  of  net  income
compared to $20.7 million of net income earned in the  third
quarter of 1994.


LIQUIDITY AND CAPITAL RESOURCES

     The  Company believes that cash provided by operations,
together  with cash provided by Cadbury, will be  sufficient
to   fund   its   working   capital  requirements,   capital
expenditures   and   principal  and  interest   requirements
described below.

    The Holding Company conducts its business through DP/7UP
and  the primary asset of the Holding Company is the  common
stock  of  DP/7UP.  The  Holding  Company  has  no  material
operations  of its own. Accordingly, the Holding Company  is
dependent   on  the  cash  flow  of  DP/7UP  to   meet   its
obligations. The Holding Company has no material obligations
other than those under the Discount Notes.  Accordingly, the
Holding  Company is not expected to have any  material  need
for  cash  until  interest  on the  Discount  Notes  becomes
payable in cash on May 1, 1998.  The Holding Company will be
required to make sinking fund payments equal to 25%  of  the
then  outstanding principal amount of the Discount Notes  in
each  of  2000 and 2001.  The Discount Notes will mature  in
2002.   The  indenture governing the Discount Notes  imposes
limits on the payment of dividends by the Holding Company.

     The  operations  of  DP/7UP do not require  significant
outlays  for  capital expenditures, and its working  capital
requirements  have historically been funded with  internally
generated  funds.  Marketing expenditures have  historically
been,  and  are expected to remain, the principal  recurring
use  of  funds for the foreseeable future. Such expenditures
are,  to  an  extent,  controllable by  management  and  are
generally  based  on  a  percentage of  unit  sales  volume.
DP/7UP's other principal use of funds in the future will  be
the payment of dividends to the Holding Company for purposes
of  making  principal and interest payments on the  Discount
Notes.

    Due to the former Credit Agreement, the Company has from
time  to  time entered into interest rate swap and  interest
rate cap agreements.  At September 30, 1995, the Company was
a counterparty to a swap expiring December 1, 1995, based on
six-month  LIBOR  with a notional amount  of  $150  million.
Interest  rate  cap  agreements, based  on  six-month  LIBOR
capped  at 6% with a total notional amount of  $250 million,
cover  all or a portion of the period from February 1,  1995
through  February  1, 1996.  Premiums for  these  agreements
accrue  to interest expense over the life of each agreement.
Any  interest rate differentials to be received or paid  are
recognized  as  adjustments to interest  expense.   The  net
effect  on  interest expense from interest rate  instruments
was  insignificant for the nine months ended  September  30,
1995   and   1994.   Market  risk  relating   to   financial
instruments  is evaluated periodically based on quotes  from
financial institutions.


                              15

<PAGE>

      The   Company   had   working  capital   deficits   of
$49.5  million  at September 30, 1995 and $57.5  million  at
December  31,  1994. The Company generally operates  with  a
working  capital deficit due to its low inventory investment
and because it has a significant amount of accrued marketing
expenses  in current liabilities.  The deficit at  September
30, 1995 was improved from the December 31, 1994 deficit  by
the  net increase in working capital components as a  result
of  the  timing of cash receipts and disbursements  and  the
seasonal  nature  of  the business.  The  Company  does  not
believe  that  such  deficits will have a  material  adverse
effect on its liquidity or operations.

     The  indenture  governing the Discount  Notes  contains
covenants   that   impose  limitations  on   the   Company's
liquidity,  including  a limitation  on  the  incurrence  of
additional indebtedness. The ability of the Company to  meet
its  debt  service  requirements  and  to  comply  with  the
financial covenants in the indenture will be dependent  upon
future performance, which is subject to financial, economic,
competitive and other factors affecting the Holding  Company
and DP/7UP, many of which are beyond their control.

     As a result of the Acquisition and the consummation  of
the  Merger,  Cadbury  owns 100% of the  outstanding  Common
Stock  of  the  Company and controls the operations  of  the
Company.   The Company is thus able to access the  resources
of  Cadbury  in  addition to cash provided by operations  to
fund its cash requirements.  The outstanding balance of  the
Credit  Agreement was repaid with cash provided  by  Cadbury
and  the  Credit Agreement was terminated, effective  as  of
March 6, 1995.


ITEM 1. LEGAL PROCEEDINGS

        See  Note  5  to  Consolidated  Condensed  Financial
        Statements   which   is   hereby   incorporated   by
        reference.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

        (a)  EXHIBITS
                 27 -        Financial Data Schedule.

        (b)  REPORTS ON FORM 8-K
             A  report on Form 8-K was filed by the  Company
             on  June 5, 1995 regarding the Company's change
             in   Certifying  Accountants  from  KPMG   Peat
             Marwick to Arthur Andersen LLP.


                              16

<PAGE>

             DR PEPPER/SEVEN-UP COMPANIES, INC.

                          SIGNATURE


Pursuant to the requirements of the Securities Exchange  Act
of  1934, the Registrant has duly caused this report  to  be
signed  on  its  behalf  by the undersigned  thereunto  duly
authorized.

             DR PEPPER/SEVEN-UP COMPANIES, INC.


Date:  November 13, 1995




                               /s/      NELSON A. BANGS
                               -----------------------------
                                        Nelson A. Bangs
                                  Vice President, Secretary
                                      & General Counsel


                              17



<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1995
<PERIOD-END>                               SEP-30-1995
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                   81,493
<ALLOWANCES>                                     1,956
<INVENTORY>                                     16,960
<CURRENT-ASSETS>                               120,582
<PP&E>                                          53,151
<DEPRECIATION>                                  34,907
<TOTAL-ASSETS>                                 556,621
<CURRENT-LIABILITIES>                          170,076
<BONDS>                                        273,408
<COMMON>                                           617
                                0
                                          0
<OTHER-SE>                                   (323,030)
<TOTAL-LIABILITY-AND-EQUITY>                   556,621
<SALES>                                        611,736
<TOTAL-REVENUES>                               611,736
<CGS>                                          104,316
<TOTAL-COSTS>                                  104,316
<OTHER-EXPENSES>                               598,022
<LOSS-PROVISION>                                   937
<INTEREST-EXPENSE>                              53,074
<INCOME-PRETAX>                              (153,841)
<INCOME-TAX>                                     (601)
<INCOME-CONTINUING>                          (153,240)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                 15,465
<CHANGES>                                            0
<NET-INCOME>                                 (168,705)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission